Anagnostics Bioanalysis GmbH:(医療機器分野)企業M&A及び提携動向

◆英語タイトル:Anagnostics Bioanalysis GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME126427D
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月12日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:オーストリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Summary

Anagnostics Bioanalysis GmbH (Anagnostics) is a pharmaceutical company. The company develops, produces and markets tests for multiplex clinical and medical research diagnostics. Its products include hyborg, integrated sepsis diagnostics, drugs of abuse screening and companion diagnostics. Anagnostics provides solutions in the fields of drugs of abuse screening, severe infections and diagnostics in the field of oncology. The company provides safety and legal support. It serves the needs of clinical laboratories. The company markets products through a network of distributors in Belgium, Denmark, Germany, India, Latvia, Turkey and Sweden. It partners with tech equity net, tech 2b, QWS, GEN-AU, FFG and ODGH. Anagnostics is headquartered in St. Valentin, Westbahnstrasse, Austria.

Anagnostics Bioanalysis GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Year, 2009 to YTD 2015 5
Anagnostics Bioanalysis GmbH, Medical Equipment Deals By Type, 2009 to YTD 2015 6
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Region, 2009 to YTD 2015 7
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Market, 2009 to YTD 2015 8
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals Summary, 2009 to YTD 2015 9
Anagnostics Bioanalysis GmbH, Medical Equipment, Deal Details 10
Venture Financing 10
Anagnostics Bioanalysis Secures US$3.82 Million In Financing 10
Partnerships 11
Anagnostics Bioanalysis Enters Into Co-Development Agreement With Scienion 11
Sony DADC Enters Into Co-Development Agreement With Anagnostics Bioanalysis 12
Anagnostics Bioanalysis Enters Into Licensing Agreement With Molzym 13
Anagnostics Bioanalysis GmbH – Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Anagnostics Bioanalysis GmbH, Medical Equipment, Key Facts 1
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Year, 2009 to YTD 2015 5
Anagnostics Bioanalysis GmbH, Medical Equipment Deals By Type, 2009 to YTD 2015 6
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Region, 2009 to YTD 2015 7
Anagnostics Bioanalysis GmbH, Deals By Market, 2009 to YTD 2015 8
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals Summary, 2009 to YTD 2015 9
Anagnostics Bioanalysis Secures US$3.82 Million In Financing 10
Anagnostics Bioanalysis Enters Into Co-Development Agreement With Scienion 11
Sony DADC Enters Into Co-Development Agreement With Anagnostics Bioanalysis 12
Anagnostics Bioanalysis Enters Into Licensing Agreement With Molzym 13
Anagnostics Bioanalysis GmbH, Key Competitors 14
Anagnostics Bioanalysis GmbH, Key Employees 15

List of Figures
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Year, 2009 to YTD 2015 5
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals by Type, 2009 to YTD 2015 6
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals By Region, 2009 to YTD 2015 7
Anagnostics Bioanalysis GmbH, Medical Equipment, Deals by Market, 2009 to YTD 2015 8

★調査レポート[Anagnostics Bioanalysis GmbH:(医療機器分野)企業M&A及び提携動向] (コード:GDME126427D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Anagnostics Bioanalysis GmbH:(医療機器分野)企業M&A及び提携動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆